Perceptive Advisors LLC Nanobiotix S.A. Transaction History
Perceptive Advisors LLC
- $3.83 Billion
- Q3 2024
A detailed history of Perceptive Advisors LLC transactions in Nanobiotix S.A. stock. As of the latest transaction made, Perceptive Advisors LLC holds 555,066 shares of NBTX stock, worth $1.72 Million. This represents 0.08% of its overall portfolio holdings.
Number of Shares
555,066
Previous 555,066
-0.0%
Holding current value
$1.72 Million
Previous $2.78 Million
14.99%
% of portfolio
0.08%
Previous 0.08%
Shares
3 transactions
Others Institutions Holding NBTX
# of Institutions
11Shares Held
6.43MCall Options Held
0Put Options Held
0-
Johnson & Johnson New Brunswick, NJ5.62MShares$17.4 Million10.31% of portfolio
-
Black Rock Inc. New York, NY239KShares$740,9240.0% of portfolio
-
Citigroup Inc3.42KShares$10,6110.0% of portfolio
-
Ubs Group Ag3.1KShares$9,6100.0% of portfolio
-
Gamma Investing LLC Foster City, CA2.86KShares$8,8560.0% of portfolio
About Nanobiotix S.A.
- Ticker NBTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 34,875,900
- Market Cap $108M
- Description
- Nanobiotix S.A., a clinical-stage biotechnology, focuses on developing product candidates for the treatment of cancer. Its lead product candidate is NBTXR3, a sterile aqueous suspension of crystalline hafnium oxide nanoparticles used for the treatment of soft tissue sarcoma, head and neck cancers, liver cancers, prostate cancer, pancreatic cance...